Skip to main content
Tech.euFundingExplorerBeta

RNatives

Finnish biotechnology company developing precision RNA-based gene regulating therapies

Total raised
€1.4M
€1,400,000
Funding rounds
1
Investors
3
distinct backers
Active since
2025-05
latest 2025-05

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood48
base rate 44% for Seed
  • In typical raise window
  • Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2025-05-27Seed€1.4MBusiness Finland,Force10,Nordic Science Investments (NSI)View deal →

Related news

Similar companies

same sector or country